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Background
Atopic dermatitis is a common chronic skin disorder
which is a subset of atopy. Atopy refers to a genetic pre-
disposition to respond immunonologically to allergens
which are generally harmless, causingover production of
immunoglobulin E (IgE) antibodies. IgE synthesis is
dependent on the activation of CD4+ Th2 subset and
their secretion of cytokines including IL 4 and IL 13.
This study was done to compare between IL 31 serum
levels in normal controls and atopic dermatitis patients
in Kelantan, Malaysia.
Methods
This was a cross-sectional study of 34 samples of atopic
dermatitispatients attending the skin clinic of Hospital
Universiti Sains Malaysia (HUSM) and Hospital Raja
Perempuan Zainab II (HRPZ II), Malaysia. 34 samples of
normal controls were taken from healthy people (those
who were free from allergic history) in HUSM. The sub-
jects of healthy controls and atopic dermatitis patients
were defined through history taking by physician. 5 ml of
blood were collected from the normal control subjects and
patients. Then, the blood was centrifuged and analyzed for
IL 31 using ELISA kits (Human IL 31 Duoset, RnD Sys-
tem). Independent T-test was used to compare the level of
serum IL 31 betweennormal control subjects and patients
with atopic dermatitis.
Results
The result showed that there was no significant difference
in IL 31 serum levels between non allergic (174.89 ±
33.08, n=34, p=0.082) and atopic dermatitis patients
(16499.46 ± 9243.56, n=34). However, there was a trend
towards a higher IL31 serum levels in atopic dermatitis
patients.
Conclusions
The results of this study suggest that although the level
of IL31 serum levels was higher, there was no significant
difference in IL 31 serum levels between atopic dermati-
tis patients and non allergic control.
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